It was hypothesized that increased cytokine levels may lead to negative outcomes of patients with severe COVID-19. In a single-centre, open-label, randomized, controlled trial conducted at the Freiburg University Medical Center 34 patients with severe COVID-19 requiring ECMO therapy were more…
Both, antiviral treatment with remdesivir and hemoadsorption using a CytoSorb® adsorption device are applied in the treatment of severe COVID-19. The CytoSorb® adsorber consists of porous polymer beads that adsorb a broad range of molecules, including cytokines but also several more…
COVID-19 is associated with a complex disorder of pro-inflammatory and anti-viral responses, including disturbed interferon signaling. In a prospective single-center registry supported by the German Center for Infection Research, we compared serum protein expression profiles of SARS-CoV-2 positive patients and more…
